MX2016004509A - Compuestos que contienen nitrogeno y su uso. - Google Patents

Compuestos que contienen nitrogeno y su uso.

Info

Publication number
MX2016004509A
MX2016004509A MX2016004509A MX2016004509A MX2016004509A MX 2016004509 A MX2016004509 A MX 2016004509A MX 2016004509 A MX2016004509 A MX 2016004509A MX 2016004509 A MX2016004509 A MX 2016004509A MX 2016004509 A MX2016004509 A MX 2016004509A
Authority
MX
Mexico
Prior art keywords
containing compounds
nitrogen containing
formula
preventing
compound
Prior art date
Application number
MX2016004509A
Other languages
English (en)
Inventor
Bhagwat Sachin
Keshav Deshpande Prasad
Sampatrao Pawar Shivaji
Bhawsar Satish
Vithalbhai Patel Mahesh
Dattatraya Yeole Ravindra
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2016004509A publication Critical patent/MX2016004509A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Se describen compuestos de la Fórmula (I), su preparación y uso en evitar o tratar una infección bacteriana. (ver Fórmula).
MX2016004509A 2013-10-11 2014-10-10 Compuestos que contienen nitrogeno y su uso. MX2016004509A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3216MU2013 IN2013MU03216A (es) 2013-10-11 2014-10-10
PCT/IB2014/065195 WO2015052682A1 (en) 2013-10-11 2014-10-10 Nitrogen containing compounds and their use

Publications (1)

Publication Number Publication Date
MX2016004509A true MX2016004509A (es) 2016-10-28

Family

ID=51945946

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004509A MX2016004509A (es) 2013-10-11 2014-10-10 Compuestos que contienen nitrogeno y su uso.

Country Status (10)

Country Link
US (1) US9434728B1 (es)
EP (1) EP3055311B1 (es)
JP (1) JP6411482B2 (es)
CN (1) CN106414444B (es)
AU (1) AU2014333436A1 (es)
CA (1) CA2926773A1 (es)
IN (1) IN2013MU03216A (es)
MX (1) MX2016004509A (es)
RU (1) RU2016113755A (es)
WO (1) WO2015052682A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160132414A (ko) 2014-03-14 2016-11-18 욱크하르트 리미티드 소듐 (2s, 5r)-6-(벤질옥시)-7-옥소-1,6-다이아자바이사이클로[3.2.1]옥테인-2-카복실레이트의 제조 공정
WO2018053057A2 (en) * 2016-09-19 2018-03-22 Merck Sharp & Dohme Corp. Process for preparing beta-lactamase inhibitor hydroxylurea intermediates
JOP20190061A1 (ar) * 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
CN111138456A (zh) * 2019-12-27 2020-05-12 山东安弘制药有限公司 一种头霉素中间体化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
EP3260551A1 (en) * 2008-06-19 2017-12-27 Astra Zeneca Holding France Use of (1r,2s,5r) 1,6-diazabicyclo [3.2.1] octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
ES2640520T3 (es) * 2011-09-13 2017-11-03 Wockhardt Limited Compuestos que contienen nitrógeno y su uso

Also Published As

Publication number Publication date
CA2926773A1 (en) 2015-04-16
CN106414444B (zh) 2018-02-02
CN106414444A (zh) 2017-02-15
AU2014333436A1 (en) 2016-05-05
JP6411482B2 (ja) 2018-10-24
JP2016532661A (ja) 2016-10-20
IN2013MU03216A (es) 2015-07-03
US9434728B1 (en) 2016-09-06
WO2015052682A1 (en) 2015-04-16
US20160257684A1 (en) 2016-09-08
RU2016113755A3 (es) 2018-06-26
EP3055311B1 (en) 2017-08-09
RU2016113755A (ru) 2017-11-16
EP3055311A1 (en) 2016-08-17

Similar Documents

Publication Publication Date Title
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
NZ713621A (en) Compounds and methods of treating infections
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
NZ733174A (en) Quinazoline derivatives used to treat hiv
IN2015DN01156A (es)
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
PH12016500225B1 (en) Novel quinoline-substituted compound
MX364486B (es) Derivados de piridazinona-amidas.
WO2015003816A3 (en) Cystobactamides
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
PH12015501088A1 (en) Dimeric compounds
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
PH12015501038A1 (en) Inhibitors of iap
ZA202002093B (en) Antibacterial compounds
MX2015005753A (es) Agentes antimicrobianos.
MX2016004509A (es) Compuestos que contienen nitrogeno y su uso.
MX2015012472A (es) Derivados de manosa para el tratamiento de infecciones bacterianas.
MX2016001858A (es) Aza-oxo-indoles novedosos para el tratamiento y profilaxis de la infeccion por el virus sincicial respiratorio.
MX2019009362A (es) Compuestos heterociclicos novedosos y sus usos en la prevencion o el tratamiento de infecciones bacterianas.
MX2016005869A (es) Inhibidor de beta-lactamasa cristalina.